Therapeutic Cancer Vaccines and Their Future Implications

The continuous progress in vaccine development witnessed in the last decades, culminated with the development of vaccines against cancers, is set to change how various cancers are treated [...].

• Publication year

  2023

• Venue

  Vaccines

• Publication date

  2023-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3390/vaccines11030660PMID 36992245PMCID 10052542
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy

  2022cited by this paper
• Cancer vaccines as promising immuno-therapeutics: platforms and current progress

  2022cited by this paper
• mRNA vaccine for cancer immunotherapy

  2021cited by this paper
• Therapeutic cancer vaccines

  2021cited by this paper
• Advances in the development of personalized neoantigen-based therapeutic cancer vaccines

  2021cited by this paper
• Adenovirus Vectors: Excellent Tools for Vaccine Development

  2021cited by this paper
• The Changing Landscape of Therapeutic Cancer Vaccines—Novel Platforms and Neoantigen Identification

  2020cited by this paper
• Therapeutic Cancer Vaccine and Combinations With Antiangiogenic Therapies and Immune Checkpoint Blockade

  2019cited by this paper
• Cancer Vaccines.

  2019cited by this paper
• mRNA vaccines — a new era in vaccinology

  2018cited by this paper
• Oncolytic virus immunotherapy: future prospects for oncology

  2018cited by this paper
• Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses

  2017cited by this paper
• Adjuvants for peptide-based cancer vaccines

  2016cited by this paper
• Key role for neutrophils in radiation-induced antitumor immune responses: Potentiation with G-CSF

  2016cited by this paper
• DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.

  2016cited by this paper
• Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer

  2013cited by this paper
• Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer

  2012cited by this paper
• Hepatitis B virus.

  2011cited by this paper
• Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

  2010cited by this paper
• Human Papillomaviruses

  2006cited by this paper
• Adjuvants--a classification and review of their modes of action.

  1997cited by this paper
• A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

  1991cited by this paper
• Prospectively randomized trial of adjuvant active‐specific immunotherapy for human colorectal cancer

  1985cited by this paper

• The search for a TNBC vaccine: the guardian vaccine

  2025cites this paper
• Advanced Technologies for Cancer Immunotherapy: Focus on Gastrointestinal Cancers.

  2025cites this paper
• Vaccination and personalized cancer vaccines focusing on common cancers in women: A narrative review.

  2025cites this paper
• Advances and challenges in cancer immunotherapy: mechanisms, clinical applications, and future directions

  2025cites this paper
• In Situ Vaccination with a Vpr-Derived Peptide Elicits Systemic Antitumor Immunity by Improving Tumor Immunogenicity

  2025cites this paper
• CanVaxKB: a web-based cancer vaccine knowledgebase

  2024cites this paper
• Prophylactic and therapeutic vaccine development: advancements and challenges

  2024cites this paper
• Cell-Based Vaccines: Frontiers in Medical Technology for Cancer Treatment

  2024cites this paper
• Unlocking cancer vaccine potential: What are the key factors?

  2024cites this paper
• All-Rounder Liposomes in Cancer Immunotherapy: Strategies and Design Applications of Engineered Liposomal Nanomaterials

  2024cites this paper
• Advances in Therapeutic Cancer Vaccines, Their Obstacles, and Prospects Toward Tumor Immunotherapy

  2024cites this paper